{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:19:28Z","timestamp":1792783168415,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T00:00:00Z","timestamp":1779580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T00:00:00Z","timestamp":1779580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of the Witwatersrand","id":[{"id":"https:\/\/ror.org\/03rp50x72","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-026-03321-4","type":"journal-article","created":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T10:41:27Z","timestamp":1779619287000},"page":"1960-1966","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Autologous whole blood clot formation with actigraft in patients receiving oral anticoagulant therapy: an ex vivo feasibility study"],"prefix":"10.1007","volume":"59","author":[{"given":"Barry Frank","family":"Jacobson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Schapkaitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie Mc","family":"Cree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,24]]},"reference":[{"issue":"1","key":"3321_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/S13643-016-0400-8","volume":"6","author":"K J\u00e4rbrink","year":"2017","unstructured":"J\u00e4rbrink K, Ni G, S\u00f6nnergren H, Schmidtchen A, Pang C, Bajpai R, Car J (2017) The humanistic and economic burden of chronic wounds: a protocol for a systematic review. Syst Rev 6(1):15. https:\/\/doi.org\/10.1186\/S13643-016-0400-8(PubMed)","journal-title":"Syst Rev"},{"key":"3321_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/J.ANNEPIDEM.2018.10.005","volume":"29","author":"L Martinengo","year":"2019","unstructured":"Martinengo L, Olsson M, Bajpai R, Soljak M, Upton Z, Schmidtchen A, Car J, J\u00e4rbrink K (2019) Prevalence of chronic wounds in the general population: systematic review and meta-analysis of observational studies. Ann Epidemiol 29:8\u201315. https:\/\/doi.org\/10.1016\/J.ANNEPIDEM.2018.10.005(PubMed)","journal-title":"Ann Epidemiol"},{"issue":"1","key":"3321_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.12968\/jowc.2017.26.1.20","volume":"26","author":"M Malone","year":"2017","unstructured":"Malone M, Bjarnsholt T, McBain AJ, James GA, Stoodley P, Leaper D, Tachi M, Schultz G, Swanson T, Wolcott RD (2017) The prevalence of biofilms in chronic wounds: a systematic review and meta-analysis of published data. J Wound Care 26(1):20\u201325. https:\/\/doi.org\/10.12968\/jowc.2017.26.1.20(The Ohio State University)","journal-title":"J Wound Care"},{"issue":"1","key":"3321_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/J.1524-475X.2008.00438.X","volume":"17","author":"C Wicke","year":"2009","unstructured":"Wicke C, Bachinger A, Coerper S, Beckert S, Witte MB, K\u00f6nigsrainer A (2009) Aging influences wound healing in patients with chronic lower extremity wounds treated in a specialized wound care center. Wound Repair Regen 17(1):25\u201333. https:\/\/doi.org\/10.1111\/J.1524-475X.2008.00438.X","journal-title":"Wound Repair Regen"},{"issue":"1","key":"3321_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/WRR.12245","volume":"23","author":"L Gould","year":"2015","unstructured":"Gould L, Abadir P, Brem H, Carter M, Conner-Kerr T et al (2015) Chronic wound repair and healing in older adults: current status and future research. Wound Repair Regen 23(1):1\u201313. https:\/\/doi.org\/10.1111\/WRR.12245","journal-title":"Wound Repair Regen"},{"key":"3321_CR6","doi-asserted-by":"publisher","DOI":"10.2147\/CWCMR.S189836","author":"TE Serena","year":"2019","unstructured":"Serena TE, Kushnir I, Kushnir A, Yaakov RA, Eckert KA (2019) The safety of an autologous whole blood clot product applied to full thickness dermal wounds in a porcine model for up to 18 days. Chronic Wound Care Manage Res. https:\/\/doi.org\/10.2147\/CWCMR.S189836","journal-title":"Chronic Wound Care Manage Res"},{"issue":"2","key":"3321_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/J.1524-475X.2009.00466.X","volume":"17","author":"GS Schultz","year":"2009","unstructured":"Schultz GS, Wysocki A (2009) Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen 17(2):153\u2013162. https:\/\/doi.org\/10.1111\/J.1524-475X.2009.00466.X","journal-title":"Wound Repair Regen"},{"key":"3321_CR8","doi-asserted-by":"publisher","DOI":"10.7547\/20-140","author":"RJ Snyder","year":"2020","unstructured":"Snyder RJ, Schultz G, Wachuku C, Rashid AM, Ead JKK (2020) Proposed mechanism of action of topically applied autologous blood clot tissue: a quintessential cellular and tissue based therapy. J Am Podiatr Med Assoc. https:\/\/doi.org\/10.7547\/20-140","journal-title":"J Am Podiatr Med Assoc"},{"issue":"9","key":"3321_CR9","doi-asserted-by":"publisher","first-page":"688","DOI":"10.12968\/JOWC.2024.0195","volume":"33","author":"R Snyder","year":"2024","unstructured":"Snyder R, Nouvong A, Ulloa J, Bowersox K, Lopez R, Sharma A et al (2024) Efficacy and safety of autologous whole blood clot in diabetic foot ulcers: a randomised controlled trial. J Wound Care 33(9):688\u2013700. https:\/\/doi.org\/10.12968\/JOWC.2024.0195","journal-title":"J Wound Care"},{"key":"3321_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/IWJ.13927","author":"Z Landau","year":"2022","unstructured":"Landau Z, Whitacre KL, Leewood C, Hawkins J, Wachuku CD (2022) Utilization of a topical autologous blood clot for treatment of pressure ulcers. Int Wound J. https:\/\/doi.org\/10.1111\/IWJ.13927","journal-title":"Int Wound J"},{"issue":"10","key":"3321_CR11","doi-asserted-by":"publisher","first-page":"874","DOI":"10.12968\/JOWC.2025.0419","volume":"34","author":"S Heisler","year":"2025","unstructured":"Heisler S, Samaan R, Lessing R, Ozker E, Snyder R (2025) Real-world outcomes of autologous whole blood clot therapy for venous leg ulcers. J Wound Care 34(10):874\u2013880. https:\/\/doi.org\/10.12968\/JOWC.2025.0419","journal-title":"J Wound Care"},{"issue":"1","key":"3321_CR12","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/S11239-015-1310-7","volume":"41","author":"AE Burnett","year":"2016","unstructured":"Burnett AE, Mahan CE, Vazquez SR, Oertel LB, Garcia DA, Ansell J (2016) Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment. J Thromb Thrombolysis 41(1):206\u2013232. https:\/\/doi.org\/10.1007\/S11239-015-1310-7","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"3321_CR13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/S12551-022-00950-W","volume":"14","author":"F Risser","year":"2022","unstructured":"Risser F, Urosev I, L\u00f3pez-Morales J, Sun Y, Nash MA (2022) Engineered molecular therapeutics targeting fibrin and the coagulation system: a biophysical perspective. Biophys Rev 14(2):427\u2013461. https:\/\/doi.org\/10.1007\/S12551-022-00950-W","journal-title":"Biophys Rev"},{"key":"3321_CR14","doi-asserted-by":"publisher","unstructured":"Park S, Park JK (2024) Back to basics: the coagulation pathway. Blood Res 59(1). https:\/\/doi.org\/10.1007\/S44313-024-00040-8","DOI":"10.1007\/S44313-024-00040-8"},{"issue":"6","key":"3321_CR15","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1160\/TH13-06-0443","volume":"110","author":"R De Caterina","year":"2013","unstructured":"De Caterina R, Husted S, Wallentin L et al (2013) Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis\u2013Task Force on Anticoagulants in Heart Disease. Thromb Haemost 110(6):1087\u20131107. https:\/\/doi.org\/10.1160\/TH13-06-0443","journal-title":"Thromb Haemost"},{"issue":"3","key":"3321_CR16","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1161\/ATVBAHA.110.202978","volume":"30","author":"E Perzborn","year":"2010","unstructured":"Perzborn E, Roehrig S, Straub A, Kubitza D, Mueck W, Laux V (2010) Rivaroxaban: a new oral factor Xa inhibitor. Arterioscler Thromb Vasc Biol 30(3):376\u2013381. https:\/\/doi.org\/10.1161\/ATVBAHA.110.202978","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"3321_CR17","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/S00784-024-05983-X","volume":"28","author":"MS Katz","year":"2024","unstructured":"Katz MS, Ooms M, Heitzer M, Naderi N, Boffano P, Lauritano D et al (2024) Platelet-rich fibrin as a hemostatic agent in dental extractions in patients taking anticoagulants or antiplatelet medication: a systematic review. Clin Oral Investig 28(11):587\u2013600. https:\/\/doi.org\/10.1007\/S00784-024-05983-X","journal-title":"Clin Oral Investig"},{"issue":"5","key":"3321_CR18","doi-asserted-by":"publisher","first-page":"e034573","DOI":"10.1136\/BMJOPEN-2019-034573","volume":"10","author":"H Alwafi","year":"2020","unstructured":"Alwafi H, Wei L, Naser AY, Sultan AA, Al-Hamad B et al (2020) Trends in oral anticoagulant prescribing in individuals with type 2 diabetes mellitus: a population-based study in the UK. BMJ Open 10(5):e034573. https:\/\/doi.org\/10.1136\/BMJOPEN-2019-034573","journal-title":"BMJ Open"},{"issue":"13","key":"3321_CR19","doi-asserted-by":"publisher","first-page":"4396","DOI":"10.3390\/JCM14134396","volume":"14","author":"MC Badescu","year":"2025","unstructured":"Badescu MC, Popescu D, Gosav EM et al (2025) The use of direct oral anticoagulants (DOACs) in the geriatric population\u2014how to overcome the challenges of geriatric syndromes. J Clin Med 14(13):4396. https:\/\/doi.org\/10.3390\/JCM14134396","journal-title":"J Clin Med"},{"issue":"6","key":"3321_CR20","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2450\/2021.0153-21","volume":"20","author":"L Dirienzo","year":"2021","unstructured":"Dirienzo L, Vitulli A, Mancazzo F, Sacco R et al (2021) Differential effect of direct oral anticoagulants on thrombin generation and fibrinolysis in patients with atrial fibrillation and venous thromboembolism. Blood Transfus 20(6):505\u2013512. https:\/\/doi.org\/10.2450\/2021.0153-21","journal-title":"Blood Transfus"},{"key":"3321_CR21","doi-asserted-by":"publisher","unstructured":"Ataullakhanov FI, Dashkevich NM, Ovsepyan RA et al (2026) Heparin and direct oral anticoagulants have different effects on the phases of activation and spatial spread of blood coagulation. Thromb Haemost 126(1). https:\/\/doi.org\/10.1055\/A-2516-7384","DOI":"10.1055\/A-2516-7384"},{"issue":"8","key":"3321_CR22","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1002\/rth2.12443","volume":"4","author":"JS Gauer","year":"2020","unstructured":"Gauer JS, Riva N, Page EM, Barnes GD et al (2020) Effect of anticoagulants on fibrin clot structure: a comparison between vitamin K antagonists and factor Xa inhibitors. Res Pract Thromb Haemost 4(8):1269\u20131281. https:\/\/doi.org\/10.1002\/rth2.12443","journal-title":"Res Pract Thromb Haemost"},{"issue":"3","key":"3321_CR23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/S10006-019-00769-Y","volume":"23","author":"AB de Mour\u00e3o","year":"2019","unstructured":"de Mour\u00e3o AB, Miron CF, de Mello Machado RJ, Ghanaati RC, Alves S, Calasans-Maia GG (2019) Usefulness of platelet-rich fibrin as a hemostatic agent after dental extractions in patients receiving anticoagulant therapy with factor Xa inhibitors: a case series. Oral Maxillofac Surg 23(3):381\u2013386. https:\/\/doi.org\/10.1007\/S10006-019-00769-Y","journal-title":"Oral Maxillofac Surg"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03321-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-026-03321-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03321-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T18:36:51Z","timestamp":1791743811000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-026-03321-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,24]]},"references-count":23,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["3321"],"URL":"https:\/\/doi.org\/10.1007\/s11239-026-03321-4","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,24]]},"assertion":[{"value":"18 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Wits Human Research Ethics Committee, Medical (approval number M240840). Written informed consent was obtained from all participants prior to study participation.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}